Literature DB >> 8008709

Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.

E G Chikhale1, K Y Ng, P S Burton, R T Borchardt.   

Abstract

With the exception of various central nervous system (CNS)-required nutrients for which specific, saturable transport systems exist, the passage of most water-soluble solutes through the blood-brain barrier (BBB) is believed to depend largely on the lipid solubility of the solutes. Most peptides, therefore, do not enter the CNS because of their hydrophilic character. Recently, utilizing homologous series of model peptides and Caco-2 cell monolayers as a model of the intestinal mucosa, it was concluded that the principal determinant of peptide transport across the intestinal cellular membrane is the energy required to desolvate the polar amide bonds in the peptide (P. S. Burton et al., adv. Drug Deliv. Rev. 7:365, 1991). To determine whether this correlation can be extended to the BBB, the permeabilities of the same peptides were determined using an in vitro as well as an in situ BBB model. The peptides, blocked on the N- and C-terminal ends, consisted of D-phenylalanine (F) residues: AcFNH2, AcF2NH2, AcF3NH2, AcF2(NMeF)NH2, AcF(NMeF)2NH2, Ac(NMeF)3NH2, and Ac(NMeF)3NHMe. A good correlation among the permeabilities of these model peptides across the bovine brain microvessel endothelial cell (BBMEC) monolayers, an in vitro model of the BBB, and their permeabilities across the BBB in situ was observed (r = 0.928, P < 0.05). The permeabilities of these peptides did not correlate with the octanol-buffer partition coefficients of the peptides (r = 0.389 in vitro and r = 0.155 in situ; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008709     DOI: 10.1023/a:1018969222130

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  The influence of peptide structure on transport across Caco-2 cells.

Authors:  R A Conradi; A R Hilgers; N F Ho; P S Burton
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

Review 2.  Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells.

Authors:  Y Takakura; K L Audus; R T Borchardt
Journal:  Adv Pharmacol       Date:  1991

Review 3.  Receptor-mediated peptide transport through the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

4.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat.

Authors:  K Ohno; K D Pettigrew; S I Rapoport
Journal:  Am J Physiol       Date:  1978-09

5.  An in situ brain perfusion technique to study cerebrovascular transport in the rat.

Authors:  Y Takasato; S I Rapoport; Q R Smith
Journal:  Am J Physiol       Date:  1984-09

Review 6.  Morphology of blood-brain interfaces.

Authors:  M W Brightman
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

7.  The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability.

Authors:  R A Conradi; A R Hilgers; N F Ho; P S Burton
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

8.  Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique.

Authors:  S Momma; M Aoyagi; S I Rapoport; Q R Smith
Journal:  J Neurochem       Date:  1987-04       Impact factor: 5.372

9.  Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.

Authors:  S Fukui; R Schwarcz; S I Rapoport; Y Takada; Q R Smith
Journal:  J Neurochem       Date:  1991-06       Impact factor: 5.372

10.  A cell culture model of the blood-brain barrier.

Authors:  L L Rubin; D E Hall; S Porter; K Barbu; C Cannon; H C Horner; M Janatpour; C W Liaw; K Manning; J Morales
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  33 in total

1.  Independence of substituent contributions to the transport of small molecule permeants in lipid bilayers.

Authors:  P T Mayer; T X Xiang; B D Anderson
Journal:  AAPS PharmSci       Date:  2000

2.  ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected].

Authors:  Stephen M Carl; David J Lindley; Debanjan Das; Pierre O Couraud; Babette B Weksler; Ignacio Romero; Stephanie A Mowery; Gregory T Knipp
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 3.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 4.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

Review 5.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

Review 6.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

7.  Transport of the antibacterial agent oxazolidin-2-one and derivatives across intestinal (Caco-2) and renal (MDCK) epithelial cell lines.

Authors:  G Ranaldi; P Seneci; W Guba; K Islam; Y Sambuy
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Predicting drug absorption from molecular surface properties based on molecular dynamics simulations.

Authors:  L H Krarup; I T Christensen; L Hovgaard; S Frokjaer
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 9.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 10.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.